Your browser is no longer supported. Please, upgrade your browser.
Fulgent Genetics, Inc.
Index- P/E34.99 EPS (ttm)2.02 Insider Own38.30% Shs Outstand22.06M Perf Week11.65%
Market Cap1.92B Forward P/E13.19 EPS next Y5.36 Insider Trans-3.09% Shs Float14.29M Perf Month56.53%
Income47.70M PEG0.48 EPS next Q2.91 Inst Own34.90% Short Float22.45% Perf Quarter91.29%
Sales135.10M P/S14.21 EPS this Y93.00% Inst Trans1.37% Short Ratio1.90 Perf Half Y271.62%
Book/sh8.47 P/B8.35 EPS next Y4.28% ROA36.60% Target Price63.00 Perf Year394.20%
Cash/sh2.76 P/C25.63 EPS next 5Y72.66% ROE43.60% 52W Range6.70 - 73.90 Perf YTD35.74%
Dividend- P/FCF- EPS past 5Y17.30% ROI-0.60% 52W High-4.30% Beta1.93
Dividend %- Quick Ratio3.40 Sales past 5Y91.00% Gross Margin69.20% 52W Low955.52% ATR5.88
Employees139 Current Ratio3.40 Sales Q/Q887.40% Oper. Margin47.30% RSI (14)69.13 Volatility9.73% 10.27%
OptionableYes Debt/Eq0.00 EPS Q/Q3090.00% Profit Margin35.30% Rel Volume1.34 Prev Close69.07
ShortableYes LT Debt/Eq0.00 EarningsNov 09 AMC Payout0.00% Avg Volume1.69M Price70.72
Recom2.20 SMA2026.44% SMA5048.47% SMA200126.77% Volume2,273,890 Change2.39%
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-19Upgrade Piper Jaffray Neutral → Overweight
Mar-01-18Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Raymond James Outperform → Mkt Perform
Jan-14-21 12:07PM  
Jan-13-21 06:59AM  
Jan-09-21 08:29AM  
Jan-08-21 11:58AM  
Jan-06-21 09:25AM  
Dec-31-20 01:05PM  
Dec-29-20 12:52PM  
Dec-21-20 01:20PM  
Dec-17-20 04:02PM  
Dec-15-20 10:07AM  
Dec-14-20 08:37AM  
Dec-11-20 11:15AM  
Dec-10-20 05:45PM  
Dec-09-20 06:50AM  
Dec-07-20 09:06AM  
Dec-05-20 04:00PM  
Dec-02-20 09:57PM  
Dec-01-20 11:10AM  
Nov-30-20 10:42AM  
Nov-27-20 06:14AM  
Nov-26-20 07:14AM  
Nov-25-20 09:17AM  
Nov-24-20 08:00AM  
Nov-23-20 08:00AM  
Nov-18-20 08:30AM  
Nov-17-20 08:54AM  
Nov-10-20 04:05PM  
Nov-09-20 04:05PM  
Nov-04-20 07:57AM  
Oct-26-20 08:00AM  
Sep-30-20 08:00AM  
Sep-22-20 07:59AM  
Sep-21-20 06:41PM  
Sep-20-20 10:18AM  
Sep-15-20 08:00AM  
Sep-09-20 08:00AM  
Sep-04-20 10:29AM  
Sep-03-20 12:20PM  
Sep-02-20 09:25PM  
Sep-01-20 09:42AM  
Aug-27-20 04:27PM  
Aug-21-20 01:28PM  
Aug-20-20 09:51AM  
Aug-17-20 07:00AM  
Aug-05-20 07:26AM  
Aug-04-20 04:05PM  
Jul-14-20 08:00AM  
Jun-25-20 12:28PM  
Jun-17-20 10:32AM  
Jun-16-20 04:05PM  
May-22-20 02:32AM  
May-18-20 06:00AM  
May-05-20 11:00AM  
May-04-20 04:05PM  
Apr-16-20 08:17AM  
Apr-09-20 08:01AM  
Mar-27-20 03:22AM  
Mar-17-20 08:00AM  
Mar-10-20 04:23PM  
Mar-02-20 09:44AM  
Feb-24-20 08:28AM  
Feb-20-20 08:00AM  
Feb-07-20 07:54AM  
Feb-06-20 03:34PM  
Jan-24-20 06:51AM  
Jan-20-20 11:30AM  
Jan-03-20 08:22AM  
Jan-02-20 10:19AM  
Dec-20-19 06:38PM  
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home Covid-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIM PAULCFO and TreasurerDec 10Sale51.9416,958880,734174,563Dec 11 06:26 PM
KIM PAULCFO and TreasurerDec 09Sale51.6010,662550,189191,521Dec 11 06:26 PM
KIM PAULCFO and TreasurerDec 02Sale46.5829,9491,395,133202,183Dec 04 04:06 PM
Xie JianChief Operating OfficerDec 02Sale46.001,00046,000431,689Dec 02 06:03 PM
Xie JianChief Operating OfficerDec 01Sale45.161,00045,160432,689Dec 02 06:03 PM
Xie JianChief Operating OfficerNov 30Sale43.223,396146,762433,689Dec 02 06:03 PM
Xie JianChief Operating OfficerNov 23Sale44.086,000264,480437,085Nov 24 05:24 PM
Xie JianChief Operating OfficerNov 20Sale42.501,00042,500443,085Nov 24 05:24 PM
Xie JianChief Operating OfficerNov 18Sale44.833,000134,500444,085Nov 19 08:15 PM
BOLGER JOHN CDirectorNov 17Option Exercise0.382,6311,0004,644Nov 18 07:48 PM
Xie JianChief Operating OfficerNov 17Sale45.343,706168,012447,085Nov 19 08:15 PM
Gao HanlinChief Scientific OfficerNov 17Sale45.4530113,680813,391Nov 18 07:50 PM
BOLGER JOHN CDirectorNov 17Sale44.244,269188,877375Nov 18 07:48 PM
KIM PAULCFO and TreasurerNov 17Sale45.453,767171,206232,132Nov 18 07:52 PM
KIM PAULCFO and TreasurerNov 16Sale46.17100,0004,616,980235,899Nov 18 07:52 PM
KIM PAULCFO and TreasurerSep 02Sale28.3242512,035335,899Sep 03 08:45 PM
Xie JianChief Operating OfficerAug 28Sale30.8244113,591601,295Sep 23 07:35 PM
KIM PAULCFO and TreasurerAug 19Sale44.1625,4071,122,039335,774Aug 19 09:14 PM
BOLGER JOHN CDirectorAug 17Option Exercise12.312,63132,3935,927Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 17Sale41.65111,2364,633,097361,181Aug 19 09:14 PM
Gao HanlinChief Scientific OfficerAug 17Sale41.111,30853,7721,281,351Aug 19 09:11 PM
BOLGER JOHN CDirectorAug 17Sale40.873,914159,9672,013Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 11Sale42.061,39658,712472,417Aug 12 04:28 PM
Xie JianChief Operating OfficerAug 03Sale27.861,97655,055601,736Aug 05 08:57 PM
KIM PAULCFO and TreasurerJun 02Sale18.064257,674433,813Jun 03 05:14 PM
BOLGER JOHN CDirectorMay 22Option Exercise2.115,13110,81211,973May 27 07:48 PM
BOLGER JOHN CDirectorMay 22Sale15.368,677133,2883,296May 27 07:48 PM
KIM PAULCFO and TreasurerMay 12Sale16.311,42123,176434,238May 13 07:13 PM